Table 1. Platelet counts of dialysis... | American Society of Hematology

Table 1.

Platelet counts of dialysis patients and healthy subjects

Group	No. subjects	Age (y)	Dialysis duration (y)	Platelet counts (×10⁹/L)	Incidence of thrombocytopenia (%)
Controls	48	49.6 ± 7.46	—	242.9 ± 38.4	—
HD patients	114	50.9 ± 14.8	13.9 ± 6.46	174.9^† ± 50.6	31.6 (36 of 114)
HCV-positive	40	49.8 ± 12.8	18.6^* ± 13.9	145.3^‡ ± 38.3	55.0 (22 of 40)
HCV-negative	74	51.7 ± 15.5	11.56^* ± 5.96	195.6^† ± 51.4	18.9 (14 of 74)
CAPD patients	43	48.5 ± 10.5	6.78 ± 4.76	210.6^1-153 ± 47.2	9.30 (4 of 43)

Group	No. subjects	Age (y)	Dialysis duration (y)	Platelet counts (×10⁹/L)	Incidence of thrombocytopenia (%)
Controls	48	49.6 ± 7.46	—	242.9 ± 38.4	—
HD patients	114	50.9 ± 14.8	13.9 ± 6.46	174.9^† ± 50.6	31.6 (36 of 114)
HCV-positive	40	49.8 ± 12.8	18.6^* ± 13.9	145.3^‡ ± 38.3	55.0 (22 of 40)
HCV-negative	74	51.7 ± 15.5	11.56^* ± 5.96	195.6^† ± 51.4	18.9 (14 of 74)
CAPD patients	43	48.5 ± 10.5	6.78 ± 4.76	210.6^1-153 ± 47.2	9.30 (4 of 43)

P < .01 vs HCV-negative patients, CAPD patients, or both.

P < .01 vs control and CAPD patients.

P < .01 vs control, HCV-negative patients, and CAPD patients.

P < .05 vs control.

Data are shown as the mean ± SD.